MOTS-c Liquid Spray · Research brief

MOTS-c COA: Reading Third-Party Purity Reports

Real Peptides Research TeamEditorial

Updated September 26, 202610 min read

56 WORDS

Short answer

The purity figure printed at the top of a peptide certificate describes what fraction of the detected material is the target compound. It says nothing about how much of that compound sits in the vial. Two different measurements, two different analytical methods, and in most cases only one of them appears anywhere on a MOTS-c COA.

Key takeaways

A MOTS-c COA documents one synthesis lot, so a certificate without a lot number that matches the vial label proves nothing about the material received.
HPLC purity is a relative area-percent measurement and excludes residual water and trifluoroacetate counterion, both of which contribute to vial mass.
Net peptide content, measured by amino acid analysis or nitrogen determination, is the only figure that quantifies actual peptide mass in the vial.
Mass spectrometry confirms the material is MOTS-c; HPLC confirms it is only MOTS-c, and a complete certificate carries both alongside the chromatogram.
Third-party testing requires a named independent laboratory, a dated report, and public access to the file before procurement, not after payment.
A peptide certificate never certifies sterility or endotoxin levels, which are separate assays with separate documentation.
MOTS-c is not an FDA-approved drug and is supplied for laboratory research use only, a status that belongs on the certificate itself.

Our team reviews batch documentation before every release, and the pattern across the wider research-compound market is consistent. The certificate exists. It looks official. Then you check the lot number against the vial, look for the name of the laboratory that ran the assay, and the paper trail quietly stops.

'What is a MOTS-c COA?'

A MOTS-c COA is a certificate of analysis covering one specific synthesis batch of MOTS-c, the 16-amino-acid mitochondrial-derived peptide encoded within the mitochondrial 12S rRNA gene region. A usable certificate reports HPLC purity by peak area, mass spectrometry confirming molecular identity, the lot number, the analysis date, and the testing laboratory. Match that lot number to the vial label first.

The common oversimplification is that a high percentage makes a certificate credible. It doesn't. A MOTS-c COA showing 99% purity with no named analytical laboratory, and a lot number that appears on every vial a supplier ships, is a marketing asset rather than analytical evidence. What follows covers the fields a certificate has to carry, why HPLC purity and net peptide content are different numbers, and how genuine independent testing differs from in-house quality control.

The fields a certificate has to carry

A certificate of analysis is a batch document, not a product document. Every line on a MOTS-c COA refers to one synthesis lot, which is why a certificate with no lot number is analytically meaningless no matter how clean the chromatogram looks.

Fields worth checking, in roughly the order they matter:

Lot or batch number, printed on both the certificate and the vial label. If the two don't match, the document describes different material.
Compound identity: the name, the amino acid sequence (MOTS-c is MRWQEMGYIFYPRKLR), the molecular formula, and a CAS number consistent with the compound named at the top of the page.
HPLC purity expressed as area percent, ideally with the chromatogram attached rather than a typed figure. Peptide assays are commonly run with UV detection at 214 nm, the wavelength where the peptide bond absorbs.
Mass spectrometry, usually ESI-MS or MALDI-TOF, confirming the observed molecular ion matches the theoretical mass of the stated sequence.
Appearance, typically described as a white to off-white lyophilised powder.
Water content and residual solvent data, where the supplier tests for them.
Date of analysis, plus the identity and signature of the laboratory that did the work.
Research-use-only statement, which belongs on the certificate as much as on the label.

A MOTS-c COA carrying identity data but no chromatogram is half a document. Mass spectrometry answers whether the material is MOTS-c. HPLC answers whether it is only MOTS-c. Neither substitutes for the other, and in our experience the missing half is almost always HPLC, because area percent is the number that exposes truncated sequences and deletion impurities left over from synthesis.

Purity percentage and net peptide content are different numbers

HPLC purity is a relative measurement. It reports the target peak as a percentage of total detected peak area, which describes the peptide fraction of the material and ignores everything the detector cannot see at that wavelength.

Two things routinely make up a real share of vial mass and never appear in that percentage. The first is water. Lyophilised peptides are hygroscopic, and residual moisture contributes weight that a purity figure does not account for. The second is counterion. Peptides purified by reverse-phase chromatography using trifluoroacetic acid carry residual trifluoroacetate (TFA) as a salt, and that salt is part of what gets weighed into the vial.

This is the point most sourcing guides skip. A batch can be 99% pure by HPLC and still contain measurably less peptide than the stated label mass, because purity and content answer different questions. Net peptide content, determined by amino acid analysis or nitrogen determination, is the figure that quantifies actual peptide mass. Most MOTS-c COA documentation in circulation reports purity and stays silent on content.

That gap matters for one reason: concentration accuracy. Concentration in a laboratory is milligrams per millilitre, and the arithmetic is only as reliable as the mass figure it starts from. If a certificate documents vial contents and a laboratory dissolves that material in 2 mL of solvent, the resulting mg per mL depends entirely on how much peptide, not how much powder, was present. A MOTS-c COA that documents content removes a variable from every calculation downstream.

Our team works with researchers who run confirmatory in-house assays, and the ones who do ask about content before they ask about purity.

Independent testing, lot traceability, and research-use-only status

Third-party testing means a laboratory with no commercial stake in the batch ran the assay. In-house quality control is legitimate and necessary, but it is a supplier grading its own work, and a MOTS-c COA carrying only internal data asks for trust the document itself cannot supply.

Three markers separate independent documentation from decoration. The laboratory is named, with a contact route that resolves to a real analytical facility. The certificate is dated and tied to a lot number that changes from batch to batch. And the file is published where anyone can read it before procurement rather than emailed once payment clears. A supplier that posts every MOTS-c COA openly accepts that customers can compare batches across time, which is a far harder standard to fake than a single PDF.

Regulatory framing sits on the same page. MOTS-c is not an FDA-approved drug. It is supplied for laboratory research use only, not for human or veterinary consumption, and a certificate that omits that line tells you something about how carefully the rest of the paperwork was assembled. Research describes MOTS-c as a mitochondrial-derived peptide, and studies report it interacts with AMPK (AMP-activated protein kinase) signalling and metabolic regulation in preclinical models. That literature exists because the compound is a research tool.

One thing a certificate does not do: it does not certify sterility or endotoxin content. Peptide certificates cover identity and purity. Microbial burden is a separate test with separate documentation, and assuming otherwise is a common misread. Everything here is educational, and Real Peptides does not provide preparation, dosing, or administration guidance for any catalog compound, because all of them are research use only.

MOTS-c COA documents compared: in-house, third-party, and none

Not every certificate carries the same evidentiary weight. The difference between a MOTS-c COA that survives scrutiny and one that doesn't is structural rather than cosmetic, and this table shows what each level of documentation actually proves.

Documentation level	What it actually proves	Where it falls short	Bottom Line
No certificate, purity stated on the product page only	Nothing analytical; it is a claim about a product line, not a measurement of a batch	No lot number, no method, no date, nothing that can be checked against the vial received	Unverifiable. A purity claim with no underlying batch document should be treated as advertising copy, not data.
In-house summary sheet, typed values, no chromatogram	That the supplier ran or commissioned some form of testing and recorded a result	Peak shape, impurity profile and integration are invisible, so truncated or deletion impurities cannot be assessed	Minimum acceptable floor for screening a supplier, but not sufficient for work where identity and purity affect the result.
In-house HPLC plus mass spectrometry, chromatogram attached, lot number matched to label	Identity by molecular ion and purity by area percent, traceable to the exact batch in hand	Still self-reported; there is no independent party confirming the chromatogram belongs to that lot	Genuinely useful documentation. Strong when lot numbers change between batches and weak when one file covers everything.
Independent laboratory HPLC plus MS, lab named and dated, file published publicly	Batch identity and purity confirmed by a party with no stake in the sale, and verifiable before purchase	Does not cover sterility, endotoxin, or net peptide content unless those assays are specifically listed	The standard worth insisting on. Public posting plus a named lab is the only combination that lets a researcher audit batch consistency over time.

What If: MOTS-c Sourcing Scenarios

What if the lot number on the certificate doesn't match the vial label?

Treat that document as unrelated to the material in hand and request the certificate issued for the lot actually shipped. Mismatched lot numbers are the single most common documentation failure we see, and the usual explanation is that a supplier keeps one flattering MOTS-c COA on file and sends it with every order regardless of which batch left the shelf. Synthesis batches vary in impurity profile even from the same manufacturer, so a certificate from a different lot carries no information about the vial in front of you.

What if a supplier will only release the certificate after purchase?

Ask for the batch document before ordering, and read the refusal as data. A supplier that publishes every MOTS-c COA before the transaction is inviting comparison across batches, which is precisely the scrutiny that weak documentation cannot survive. Certificates held back until after payment also remove any pre-purchase opportunity to check that the sequence, molecular formula and CAS number on the page match the compound being sold.

What if the mass spectrometry result is a few daltons off the theoretical mass?

Query it with the supplier and ask which impurity the analytical laboratory assigned to the difference. Small positive mass shifts in peptides containing methionine often reflect oxidation, since methionine sulfoxide adds 16 daltons per residue, and MOTS-c contains two methionines in its sequence. That is a plausible chemical explanation rather than an automatic problem, but a certificate that shows the deviation without explaining it leaves the identity confirmation incomplete.

The Unglamorous Truth About Peptide Purity Claims

Here's the honest answer: the purity percentage is the least informative number on the page. Almost every supplier reports something above 98%, the figure is trivially easy to type, and a relative area percent cannot tell you how much peptide a vial holds or whether the assay was even run on that batch. The informative parts of a MOTS-c COA are the boring ones. Lot number. Analysis date. The name of the laboratory. The attached chromatogram. Those four fields either connect the document to the material in your hand or they don't, and no percentage rescues a certificate that fails that test.

Real Peptides publishes batch documentation in one place, covering catalog compounds including the MOTS-c 10mg vial and the MOTS-c liquid spray, with current certificates held in the batch certificate library. Researchers comparing formats can read the MOTS-c research overview, review the oral research compound range, or work through the full research catalog. All compounds are supplied for laboratory research use only.

A MOTS-c COA is a snapshot of one batch on one day, taken by one laboratory, using one method. Read that way, it is genuinely useful. Read as a permanent statement about a product line, it is worthless, and that is the confusion most of this market quietly depends on. The suppliers worth buying from are the ones whose documentation gets more convincing the longer you look at it, batch after batch, because consistency across lots is the thing no single certificate can manufacture.

References

Peer-reviewed sources on MOTS-c indexed in PubMed, listed for research context. Real Peptides supplies MOTS-c for laboratory research use only.

MOTS-c improves intrinsic muscle mitochondrial bioenergetic health and efficiency in a PGC-1α/AMPK-dependent manner. Free radical biology & medicine, 2026. PMID 41520850. doi:10.1016/j.freeradbiomed.2026.01.002
Humanin and MOTS-c Attenuate Atrial Fibrillation by Suppressing Fibrosis and Mitochondrial Dysfunction. Biomedicines, 2026. PMID 42193373. doi:10.3390/biomedicines14051048
MOTS-c, a mitochondrial-derived peptide, ameliorates lysosomal membrane permeability and improves survival of soft tissue transplantation. Autophagy, 2026. PMID 42153537. doi:10.1080/15548627.2026.2677180
Mitochondrial-derived peptide MOTS-c targets SLC7A11 to preserve spermatogenesis by suppressing ferroptosis. Free radical biology & medicine, 2026. PMID 41933740. doi:10.1016/j.freeradbiomed.2026.03.074
MOTS-c attenuates cardiac dysfunction following high altitude exposure by promoting mitophagy. Free radical biology & medicine, 2026. PMID 41654147. doi:10.1016/j.freeradbiomed.2026.01.064
Mitochondrial-encoded peptide MOTS-c prevents pancreatic islet cell senescence to delay diabetes. Experimental & molecular medicine, 2025. PMID 40855115. doi:10.1038/s12276-025-01521-1
MOTS-c attenuates mitochondrial dysfunction induces pyroptosis and cartilage degradation in osteoarthritis via an Nrf2-Dependent Mechanism. Free radical biology & medicine, 2025. PMID 41043625. doi:10.1016/j.freeradbiomed.2025.09.056
MOTS-c Promotes Glycolysis via AMPK-HIF-1α-PFKFB3 Pathway to Ameliorate Cardiopulmonary Bypass-induced Lung Injury. American journal of respiratory cell and molecular biology, 2025. PMID 40035775. doi:10.1165/rcmb.2024-0533OC

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

Start with the lot number and confirm it matches the vial label, because the certificate only describes that one synthesis batch. Then check compound identity (name, sequence MRWQEMGYIFYPRKLR, molecular formula, CAS number), the HPLC purity figure with its chromatogram, and the mass spectrometry result confirming the molecular ion. Finish with the analysis date and the name of the laboratory that ran the assays.

It means an analytical laboratory with no commercial interest in the sale performed the identity and purity assays on that batch. Genuine third-party testing names the laboratory, dates the report, ties it to a specific lot number, and publishes the file so it can be read before purchase. In-house testing alone is the supplier assessing its own material, which is useful but not independent.

MOTS-c is sold for laboratory research use only and is not an FDA-approved drug, so it is not offered for human or veterinary consumption in any form. Suppliers such as Real Peptides list it as a catalog compound for researchers and laboratories, supplied with a certificate of analysis for the batch. It is not a therapeutic product and no dosing or administration guidance accompanies it.

Pricing varies widely by vial size, format, purity specification and how much analytical documentation a supplier funds per batch. Independent third-party HPLC and mass spectrometry on every lot adds real cost, which is part of why the cheapest listings often come with the thinnest paperwork. Comparing the certificate alongside the price is the only way to judge whether the two are proportionate.

They answer different questions and neither is optional. Mass spectrometry confirms the material is MOTS-c by matching the observed molecular ion to the theoretical mass of the stated sequence. HPLC, typically with UV detection at 214 nm, reports what percentage of detected material is the target peak, which is how truncated sequences and synthesis-related impurities become visible.

Without batch documentation there is no evidence the vial contains the stated compound, no impurity profile, and no way to attribute anomalous assay results to the material rather than the method. Undocumented material also cannot be audited retrospectively, so a laboratory that discovers a problem three experiments later has no reference data to review. For research use, that is a reproducibility failure waiting to happen.

No. Peptide certificates of analysis cover identity and purity, typically by HPLC and mass spectrometry, sometimes with appearance and water content. Sterility and bacterial endotoxin are separate assays with separate documentation, and assuming a purity certificate covers microbial burden is one of the more common misreads in peptide sourcing.

Because purity and peptide content are different measurements. HPLC purity is the target peak as a percentage of detected peak area, while residual water and trifluoroacetate counterion from reverse-phase purification both contribute to the weighed mass without appearing in that percentage. Two batches with identical purity figures can therefore contain different amounts of actual peptide, which shifts every concentration calculation made from them.

No. Real Peptides supplies research-use-only compounds with third-party COAs and purity documentation. Product pages and support cover verification, storage and handling of sealed vials, and ordering — nothing about laboratory procedure, which is the responsibility of the purchasing researcher and their institution.

A certificate documents the condition of a batch on the date the assays were performed, and there is no universal regulatory expiry period for research peptide certificates. Some suppliers list a retest or re-analysis date; others do not, and the literature does not specify a fixed interval. The practical test is whether the certificate you are reading corresponds to the lot number on the vial you received.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA